Nancy Sullivan (biologist)
Nancy J. Sullivan | |
|---|---|
Sullivan in 2015 | |
| Born | Nancy Jean Sullivan |
| Alma mater | Harvard T.H. Chan School of Public Health (ScD, MS) Merrimack College (BS) |
| Known for | Viral immunology, vaccine development, filovirus biology |
| Scientific career | |
| Fields | Cell biology, Virology, Immunology |
| Institutions | National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University |
| Thesis | Determinants of HIV-1 envelope glycoprotein-mediated fusion and antibody neutralization (1997) |
| Doctoral advisor | Joseph Sodroski |
| Website | https://www.bu.edu/neidl/profile/nancy-j-sullivan/ |
Nancy Jean Sullivan is an American cell biologist, virologist, and immunologist. She has served as the director of the National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University from December 2022 until May 2025. Previously, she was chief of the Biodefense Research Section at the Vaccine Research Center (VRC) in the National Institute of Allergy and Infectious Diseases (NIAID).
Sullivan was awarded the 2020 Science, Technology, and Environment Service to America Medal for the development of ansuvimab, an FDA-approved monoclonal antibody for the treatment of Ebola virus disease.
In 2014, Time magazine recognized all health-care workers and scientists tackling the Ebola viral outbreak in West Africa as its Person of the Year; specifically recognizing Sullivan's relentless scientific efforts in the development of vaccines targeting the disease.